AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamergernews2022-01-26T14:29:08+00:00January 26th, 2022|Fierce Pharma|
FDA chides Eli Lilly for second misleading ad in 2 months, this time for diabetes blockbuster Trulicitynews2022-01-25T17:55:57+00:00January 25th, 2022|Fierce Pharma|
FDA chides Eli Lilly for 2nd misleading ad in 2 months, this time for diabetes blockbuster Trulicitynews2022-01-25T17:55:57+00:00January 25th, 2022|Fierce Pharma|
Johnson & Johnson CEO: Consumer health split won’t interfere with our ‘more aggressive’ approach to M&Anews2022-01-25T16:34:38+00:00January 25th, 2022|Fierce Pharma|
Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label usenews2022-01-25T16:19:29+00:00January 25th, 2022|Fierce Pharma|
Samsung Biologics outlines mRNA ambitions as “Super Plant” speeds toward completionnews2022-01-25T15:56:28+00:00January 25th, 2022|Fierce Pharma|
EpiPen rival raises $39M to fund smaller, longer-lasting productnews2022-01-25T14:11:44+00:00January 25th, 2022|Fierce Pharma|
Roche’s aim to widen Evrysdi’s label nabs speedy FDA review in young spinal muscular atrophy patientsnews2022-01-25T14:11:30+00:00January 25th, 2022|Fierce Pharma|
WuXi STA opens new sterile manufacturing line at Wuxi City sitenews2022-01-25T13:31:37+00:00January 25th, 2022|Fierce Pharma|
Pfizer goes subtle on vaccine but big on human spirit in latest ad spotnews2022-01-25T13:07:47+00:00January 25th, 2022|Fierce Pharma|
